Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Bäck, Magnus ^a,b   Qiu, Hong ^a   Haeggström, Jesper Z ^a   Sakata, Kiyoto ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelium; Histamine; Retinoic acid; Thromboxane

Indexed keywords

5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; ANTIHISTAMINIC AGENT; CALCIMYCIN; CALCIUM IONOPHORE; CHEMOATTRACTANT; HISTAMINE; INDOMETACIN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; MESSENGER RNA; RAMATROBAN; RETINOIC ACID; THROMBOXANE; THROMBOXANE RECEPTOR BLOCKING AGENT; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM INJURY; GUINEA PIG; HISTAMINE RELEASE; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASOCONSTRICTION; ANIMAL; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ANIMALS; AORTA; GUINEA PIGS; HISTAMINE RELEASE; LEUKOTRIENE B4; MALE; RECEPTORS, LEUKOTRIENE B4; THROMBOXANES; TRETINOIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 18544395256     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00699.2003     Document Type: Article

References (48)

1. Allen SP, Chester AH, Dashwood MR, Tadjkarimi S, Piper PJ, and Yacoub MH. Preferential vasoconstriction to cysteinyl leukotrienes in the human saphenous vein compared with the internal mammary artery. Implications for graft performance. Circulation 90: 515-524, 1994.
2. Bäck M. Functional characteristics of cysteinyl-leukotriene receptor subtypes. Life Sci 71: 611-622, 2002.
3. Bäck M. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle. Acta Physiol Scand Suppl 648: 1-55, 2002.
4. Bäck M, Norel X, Walch L, Gascard JP, de Montpreville V, Dahlén SE, and Brink C. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. Eur J Pharmacol 401: 389-395, 2000.
5. Bäck M, Walch L, Norel X, Gascard JP, Mazmanian G, and Brink C. Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. Acta Physiol Scand 174: 9-15, 2002.
6. 4 receptor: comparison to its human orthologue. Eur J Pharmacol 380: 203-213, 1999.
7. Brink C, Dahlén SE, Drazen J, Evans JF, Hay DWP, Nicosia S, Serhan CN, Shimizu T, and Yokomizo T. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55: 195-227, 2003.
8. 2. Circ Res 72: 1023-1034, 1993.
9. Chadwick CC, Shaw LJ, and Winneker RC. TNF-α and 9-cis-retinoic acid synergistically induce ICAM-1 expression: evidence for interaction of retinoid receptors with NF-kappa B. Exp Cell Res 239: 423-429, 1998.
10. Dahlén SE, Björk J, Hedqvist P, Arfors KE, Hammarström S, and Lindgren JÅ. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 78: 3887-3891, 1981.
11. 4 acts indirectly. Acta Physiol Scand 118: 393-403, 1983.
12. 2+-binding protein family in guinea-pig smooth muscle. Cell Calcium 33: 1-10, 2003.
13. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, and Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350: 29-37, 2004.
14. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, and Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286: 264-265, 1980.
15. Funk CD. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294: 1871-1875, 2001.
16. Gaetano C, Catalano A, Illi B, Felici A, Minucci S, Palumbo R, Facchiano F, Mangoni A, Mancarella S, Muhlhauser J, and Capogrossi MC. Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo. Circ Res 88: E38-E47, 2001.
17. 1) is crucial for ligand-induced, G-protein-coupled receptor-specific kinase 6-mediated desensitization. J Biol Chem 277: 31567-31576, 2002.
18. 1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immun 4: 965-973, 2003.
19. Gruetter CA, Lemke SM, Valentovic MA, and Szarek JL. Evidence that histamine is involved as a mediator of endothelium-dependent contraction induced by A23187 in bovine intrapulmonary vein. Eur J Pharmacol 257: 275-283, 1994.
20. 4 from human leukocytes. FEBS Lett 130: 107-112, 1981.
21. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SFA, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, and Stefansson K. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36: 233-239, 2004.
22. 4 action on endothelium mediates augmented neutrophil/ endothelial adhesion. Proc Natl Acad Sci USA 81: 2191-2193, 1984.
23. 4 receptor expressed on eosinophils. J Exp Med 188: 1063-1074, 1998.
24. 2 as an endothelium-derived contracting factor and its interaction with endothelium-derived nitric oxide. J Hypertens 9: 729-736, 1991.
25. Kooistra T, Lansink M, Arts J, Sitter T, and Toet K. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells. Eur J Biochem 232: 425-432, 1995.
26. Lansink M and Kooistra T. Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction. Blood 88: 531-541, 1996.
27. 4. J Lab Clin Med 124: 723-729, 1994.
28. 4 receptor. Biochem J 342: 79-85, 1999.
29. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ, and Shih W. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91: 120-126, 2002.
30. 4-activated human endothelial cells promote transendothelial neutrophil migration. J Leukoc Biol 62: 203-209, 1997.
31. 4 receptor-1 expression during neutrophilic differentiation of HL-60 cells. Biochem Biophys Res Commun 309: 114-119, 2003.
32. 4 hydrolase in guinea pig tissues. J Biol Chem 265: 7520-7525, 1990.
33. 4. Nat Immun 4: 974-981, 2003.
34. 4 induced hyperadhesiveness of endothelial cells for neutrophils. J Immunol 152: 262-269, 1994.
35. Preisig-Müller R, Schnitzler MMY, Derst C, and Daut J. Separation of cardiomyocytes and coronary endothelial cells for cell-specific RT-PCR. Am J Physiol Heart Circ Physiol 276: H413-H416, 1999.
36. Romppanen EL, Savolainen K, and Mononen I. Optimal use of the fluorescence PicoGreen dye for quantitative analysis of amplified polymerase chain reaction products on microplate. Anal Biochem 270: 111-114, 2000.
37. Runde V, Aul C, Heyll A, and Schneider W. All-trans-retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia. Blood 79: 534-535, 1992.
38. 4 in the guinea pig lung involves a vascular component. Br J Pharmacol 141: 449-456, 2004.
39. 4 from human polymorphonuclear leukocytes. J Biol Chem 271: 17944-17948, 1996.
40. 4. Prostaglandins Med 6: 153-159, 1981.
41. 1 receptor. Eur J Biochem 286: 2578-2586, 2001.
42. Spanbroek R, Gräbner R, Lötzer K, Hildner M, Urbach A, Rühling K, Moos MPW, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plenz G, Robenek H, Salbach P, Kühn H, Rådmark O, Samuelsson B, and Habenicht AJR. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100: 1238-1243, 2003.
43. Stanke-Labesque F, Devillier P, Veitl S, Caron F, Cracowski JL, and Bessard G. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats. Cardiovasc Res 49: 152-160, 2001.
44. 4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J Immunol 168: 3570-3576, 2002.
45. 1 mediates early effector T cell recruitment. Nat Immun 4: 982-990, 2003.
46. 4 that mediates chemotaxis. Nature 387: 620-624, 1997.
47. 2: a new therapeutic target in inflammation and immunological disorders. J Exp Med 192: 421-431, 2000.
48. Yoshizawa M, Miyazaki H, and Kojima S. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors. J Cell Physiol 176: 565-573, 1998.